Analysis of the expression of HMGB-1, CXCL16, miRNA-30a, and TGF-β1 in primary nephritic syndrome patients and its significance.
We investigated the expression levels of high-mobility group box protein 1 (HMGB-1), CXC chemokine ligand 16 (CXCL16), microRNA (miRNA)-30a and transforming growth factor ß1 (TGF-ß1) in primary nephritic syndrome (PNS) patients and the clinical significance of this expression. A total of 56 patients with PNS were included in the PNS group, while 50 healthy subjects formed the normal control group. Serum levels of HMGB-1, CXCL16, miRNA-30a, and urinary TGF-ß1 concentrations were quantified along with other biochemical indices, including serum albumin, triglyceride (TG), total cholesterol (TC), low-density lipoprotein (LDL), high-density lipoprotein, and urinary proteins. The correlation between levels of HMGB-1, CXCL16, miRNA-30a, and TGF-ß1 and biochemical indexes was further analyzed. PNS group patients had significantly higher levels of HMGB-1, CXCL16, miRNA- 30a, and TGF-ß1 compared to the control group (P < 0.05). PNS patients also had higher 24-h urinary protein, TG, TC, and LDL levels but lower serum albumin compared to subjects in the control group (P < 0.05). Serum HMGB-1, CXCL16, miRNA-30a, and urinary TGF-ß1 levels were all negatively correlated with serum albumin levels, but were positively correlated with TG, TC, LDL, and 24-h urinary protein (P < 0.05 in all cases). Additionally, a positive correlation existed among serum HMGB-1, CXCL16, miRNA-30a, and urinary TGF-ß1 levels (P < 0.01). HMGB-1, CXCL16, miRNA-30a, and urinary TGF-ß1 were highly expressed in PNS patients and may play important roles in the pathogenesis and development of PNS.
Nephrology Department of PLA, 89th Hospital, Weifang, China.
W J
WJ
Wang
Orthopaedic Institute of PLA, 89th Hospital, Weifang, China.
X Q
XQ
Qu
Department of Clinical Laboratory, The People's Hospital of Gaomi City, Gaomi, Shandong, China.
X M
XM
Yu
Nephrology Department of PLA, 89th Hospital, Weifang, China.
W
W
Lv
Department of Urology of PLA, 89th Hospital, Weifang, China.
H Y
HY
Yu
D000328:Adult; D000368:Aged; D015415:Biomarkers; D016022:Case-Control Studies; D000075743:Chemokine CXCL16; D019743:Chemokines, CXC / Q000097:blood / Q000235:genetics*; D005260:Female; D015870:Gene Expression; D024243:HMGB1 Protein / Q000097:blood / Q000235:genetics*; D006801:Humans; D008297:Male; D035683:MicroRNAs / Q000097:blood / Q000235:genetics*; D008875:Middle Aged; D009404:Nephrotic Syndrome / Q000097:blood / Q000235:genetics* / Q000652:urine; D051116:Receptors, Scavenger / Q000097:blood / Q000235:genetics*; D053773:Transforming Growth Factor beta1 / Q000235:genetics* / Q000652:urine
D015415:Biomarkers; C423727:CXCL16 protein, human; D000075743:Chemokine CXCL16; D019743:Chemokines, CXC; D024243:HMGB1 Protein; C546086:MIRN30b microRNA, human; D035683:MicroRNAs; D051116:Receptors, Scavenger; D053773:Transforming Growth Factor beta1